Praxis Precision Medicines Inc
NASDAQ:PRAX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Praxis Precision Medicines Inc
NASDAQ:PRAX
|
US |
|
Christian Dior SE
OTC:CHDRF
|
FR |
|
Perusahaan Gas Negara Tbk PT
IDX:PGAS
|
ID |
|
P
|
Profoto Holding AB (publ)
STO:PRFO
|
SE |
|
Caldwell Partners International Inc
TSX:CWL
|
CA |
|
G
|
Gigante Salmon AS
OSE:GIGA
|
NO |
|
A
|
Aviva PLC
XBER:GU8
|
UK |
|
Openn Negotiation Ltd
ASX:OPN
|
AU |
|
S
|
Shenzhen Edadoc Technology Co Ltd
SZSE:301366
|
CN |
Wall Street
Price Targets
PRAX Price Targets Summary
Praxis Precision Medicines Inc
According to Wall Street analysts, the average 1-year price target for
PRAX
is 629.98 USD
with a low forecast of 131.3 USD and a high forecast of 1 307.25 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is PRAX's stock price target?
Price Target
629.98
USD
According to Wall Street analysts, the average 1-year price target for
PRAX
is 629.98 USD
with a low forecast of 131.3 USD and a high forecast of 1 307.25 USD.